Inventiva (IVA) filed a mixed shelf registration statement to raise $300 million from the sale of the company's securities, according to a Tuesday filing with the US Securities and Exchange Commission.
The filing covers the potential sale of ordinary shares, American depositary shares representing ordinary shares, and warrants to purchase ordinary shares or ADSs.
Inventiva said it plans to use proceeds to fund research and development of lanifibranor, as well as for working capital and general corporate purposes.
The company also entered into a new at-the-market equity offering program to sell up to $100 million of ordinary shares in the form of ADSs, each representing one ordinary share. The amount is included in the total $300 million shelf registration.
Comments